We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antithrombotics

News List

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients firstwordpharma
August 05, 2021
A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances .
NIH launches antithrombotics trials in COVID-19 patients europeanpharmaceuticalreview
September 16, 2020
The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots.
Aplagon and Cadila Pharmaceuticals to develop APAC first-in-class antithrombotics targeting vascular pharmaasia
September 22, 2017
A new Aplagon-Cadila Pharmaceuticals partnership is focused on APAC first-in-class antithrombotics, with clinical trials expected to commence in 2019.